Immunomodulation on tumor immune microenvironment in acquired targeted therapy resistance and implication for immunotherapy resistance
Open Access
- 8 March 2025
- journal article
- review article
- Published by Elsevier in Translational Oncology
- Vol. 54, 102353
Abstract
No abstract availableKeywords
Funding Information
- Taipei City Government Department of Health
- Executive Yuan Republic of China Ministry of Education
- National Science and Technology Council (111-2314-B-A49-030-MY3)
This publication has 170 references indexed in Scilit:
- Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategiesMedcomm, 2024
- PD‐L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistanceHead & Neck, 2021
- Suppression of tumor immune microenvironment via microRNA‐1 after epidermal growth factor receptor‐tyrosine kinase inhibitor resistance acquirement in lung adenocarcinomaCancer Medicine, 2020
- Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancerInternational Journal of Cancer, 2020
- EGFR‐targeted therapy alters the tumor microenvironment in EGFR‐driven lung tumors: Implications for combination therapiesInternational Journal of Cancer, 2019
- EGFR–TKI-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients With Non–Small Cell Lung CancerJAMA Oncology, 2018
- Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitorsCancer, 2014
- The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patientsCancer Immunology, Immunotherapy, 2008
- Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodiesCancer and Metastasis Reviews, 2005
- A phase II trial of ZD1839 (Iressa™) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancerInvestigational New Drugs, 2005